The Efficacy of Surfactant Replacement Therapy in the Growth-Restricted Preterm Infant: What is the Evidence?

Frontiers in Pediatrics

Atul Malhotra¹ 

关键词: premature;    IUGR;    fetal growth restriction;    FGR;    lungs;    RDS;    BPD;   

DOI  :  10.3389/fped.2014.00118

学科分类：儿科学

来源: Frontiers

【 摘 要 】

Background: Surfactant replacement therapy (SRT) is an integral part of management of preterm surfactant deficiency respiratory distress syndrome (RDS). Its role in the management of RDS has been extensively studied. However, its efficacy in the management of lung disease in preterm infants born with intrauterine growth restriction (IUGR) has not been systematically studied.

【 授权许可】

CC BY